• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Five steps to a better FDA

Five steps to a better FDA

October 11, 2011 By MassDevice staff

FDA

Facing increasing public mistrust and growing pressure from medical device and drug makers, the FDA’s plan for improving its review processes may need some help from industry.

Device and drug makers would do well to support a bump in the FDA’s budget and a ban on advisory committee members with conflicts of interest, according to Xconomy columnist Luke Timmerman.

Industry should also get behind a ban on direct-to consumer ads, full disclosure of FDA response letters and strong regulatory science programs at business and medical schools, Timmerman wrote.

Just a day after FDA chief Dr. Margaret Hamburg released a report detailing the agency’s mission to spur innovation in medical devices, the  National Venture Capitalists Assn.’s Medical Innovation & Competitiveness Coalition unveiled its own report pointing the finger at the federal watchdog agency as the main reason device companies are fleeing the U.S. and investors are wary of opening their pocketbooks.

Surveys show that about half of respondents in the U.S. think the agency is doing a bad job. The new device pipeline is "not commensurate with the medical and public health need," Hamburg said during a conference call last week.

"Government and industry now pour $95 billion a year into biomedical R&D, and somehow society keeps getting a stagnant number of new drugs coming out the other end," Timmerman wrote. "It’s a serious concern for patients."

The FDA’s blueprint for boosting the device space includes calls for improved "consistency and clarity in the medical device review process," rebuilding its outreach offering for small businesses and focusing on developing personalized medicine.

Venture capitalists, on the other hand, blame the agency’s unpredictability for the ongoing slide in med-tech funding.

"This report confirms what has been suspected for some time, which is that venture capitalists are shifting investment capital away from lifesaving and life-sustaining products and into areas less regulated by the FDA as well as into other countries," said Dr. Beth Seidenberg, chairwoman of the MedIC coalition and a partner at Kleiner Perkins Caufield & Byers, in prepared remarks. "This trend is one that the venture industry and, we believe, the FDA, wants desperately to reverse."

Filed Under: Food & Drug Administration (FDA), News Well Tagged With: 510(k) reforms, National Venture Capital Assn., Venture Capital/Private Equity

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy